Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis
Clinical trial NCT03112681 · COMPLETED
Trial details
- NCT number
- NCT03112681
- Sponsor
- Zydus Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-18
- Primary completion
- 2020-08-07
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.